.png){kind=icon}
返回
.png){kind=icon}
.png){kind=icon}
摘要
En 中文
Allergen immunotherapy involves exposing a patient to a gradually escalating dose of a specific allergen with the intention of decreasing allergic and Inflammatory responses, ultimately leading to a sustained decrease in allergic symptoms. A build-up phase (once weekly injections) is followed by a maintenance phase (once monthly injections) that generally continues for 3 to 5 years. Allergen immunotherapy is indicated for select patients with allergic rhinoconjunctivitis, allergic asthma, and stinging insect hypersensitivity. The safety and efficacy of allergen immunotherapy have been confirmed by numerous well-designed studies. Recent research has helped uncover the mechanisms by which allergen immunotherapy exerts its therapeutic effect, paving the way for the development of safer, more effective therapy for a wider range of allergic diseases.
Keyword:
LONG-TERM PREVENTION
DOUBLE-BLIND
FOLLOW-UP
SUBLINGUAL IMMUNOTHERAPY
FATAL REACTIONS
ANTI-IGE
ASTHMA
CHILDREN
EFFICACY
HYPERSENSITIVITY
期刊
IF:
6.7
论文数:
1.0W
被引数:
2.0W
机构
暂无机构信息
引用论文
Effect of the particle size on the activity of MoOxCy catalysts for the isomerization of heptane.png)
.png){kind=icon}
PREAI
.png){kind=icon}
分享.png){kind=icon}
收藏分享收藏
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis豚草toll样受体9激动剂疫苗治疗变应性鼻炎
OAAI
OAAI分享收藏
查看更多内容